Biomarkers sFlt and PlGF for diagnosis and therapy of pulmonaryhypertension
The present invention relates to the use of biomarkers sFlt and PlGF for diagnosis, early recognition and risk stratification of pulmonary hypertension. Thereby an immunologic test (ELISA) for the determination of blood levels of sFlt and PIGF in patients is preferred.
Further Information: PDF
INNOVECTIS Gesellschaft für Innovations-Dienstleistungen mbH
Phone: +49 (0)69/2561632-0
Contact
Dr. Otmar Schöller
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Results for control of pollutants in water
Brazilian scientists tested a simple and sustainable method for monitoring and degrading a mixture of polycyclic aromatic hydrocarbons, compounds present in fossil fuels and industrial waste. An article published in the journal Catalysis…
A tandem approach for better solar cells
Perovskite-based solar cells were first proved in 2009 to have excellent light-absorbing properties of methylammonium lead bromide and methylammonium lead iodide, collectively referred to as lead halide perovskites or, more…
The behavior of ant queens is shaped by their social environment
Specialization of ant queens as mere egg-layers is reversible / Queen behavioral specialization is initiated and maintained by the presence of workers. The queens in colonies of social insects, such…